JAK2 c.163_165delinsTTT ;(p.L55F)

Variant ID: 9-5022150-CTG-TTT

NM_004972.3(JAK2):c.163_165delinsTTT;(p.L55F)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.

Signal Transduction And Targeted Therapy
Carter, Jenna L JL; Hege, Katie K; Yang, Jay J; Kalpage, Hasini A HA; Su, Yongwei Y; Edwards, Holly H; Hüttemann, Maik M; Taub, Jeffrey W JW; Ge, Yubin Y
Publication Date: 2020-12-18

Variant appearance in text: JAK2: Leu55Phe
PubMed Link: 33335095
Variant Present in the following documents:
  • Main text
  • 41392_2020_Article_361.pdf
View BVdb publication page



AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.

Bmc Medical Genomics
Wünsch, Christian C; Banck, Henrik H; Müller-Tidow, Carsten C; Dugas, Martin M
Publication Date: 2020-02-04

Variant appearance in text: JAK2: L55F
PubMed Link: 32019565
Variant Present in the following documents:
  • 12920_2020_668_MOESM6_ESM.xls, sheet 1
View BVdb publication page